© 2020 MJH Life Sciences and OncLive. All rights reserved.
October 09, 2019
Kelly E. Westbrook, MD, discusses combatting tumor heterogeneity in patients with HER2-positive breast cancer.
September 20, 2019
Kelly E. Westbrook, MD, discusses the 3-year follow-up data on the KRISTINE trial in stage II or III HER2-positive breast cancer.